Skip to main content

Table 2 Frequency distribution of reductions in intensity and prevalence of P. falciparum oocyst stage infections in A. stephensi for 188 serum samples tested in SMFA

From: Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum

Range of TBA

Number (%) of test sera with corresponding reduction in oocyst infection

Intensity (geometric mean oocysts/mosquito)

Prevalence (percent mosquitoes with oocysts)

100%

31 (16.5%)

31 (16.5%)

90-99%

94 (50.0%)

70 (37.2%)

60-89%

38 (20.2%)

31 (16.5%)

30-59%

17 (9.0%)

16 (8.5%)

0-29%

3 (1.6%)

31 (16.5%)

<0%

5 (2.7%)

9 (4.8%)